Nadezda Machkova

Affiliations

Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.

Publications (6)

Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?

Crohn's & colitis 360

Avec: Karin Cerna , Dana Duricova , Martin Lukas , Martin Kolar , Nadezda Machkova , Veronika Hruba , Katarina Mitrova , Kristyna Kubickova , Marta Kostrejova , Jakub Jirsa , Kristyna Kastylova , Stepan Peterka , Gabriela Vojtechova , Milan Lukas

Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical Centre.

Journal of Crohn's & colitis

Avec: Martin Lukas , K Malickova , M Kolar , M Bortlik , M Vasatko , N Machkova , V Hruba , D Duricova , Milan Lukas

Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.

Inflammatory bowel diseases

Avec: Karin Cerna , Dana Duricova , Martin Lukas , Nadezda Machkova , Veronika Hruba , Katarina Mitrova , Kristyna Kubickova , Marta Kostrejova , Vladimir Teplan , Martin Vasatko , Kristyna Kastylova , Milan Lukas

Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.

Inflammatory bowel diseases

Avec: Dana Duricova , Eva Dvorakova , Ondrej Hradsky , Katarina Mitrova , Marianna Durilova , Jana Kozeluhova , Pavel Kohout , Kristyna Zarubova , Jiri Bronsky , Nora Hradska , Eva Bronska , Miroslava Adamcova , Nadezda Machkova , Veronika Hruba , Martin Bortlik , Martin Lukas , Karin Malickova , Milan Lukas

Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.

Journal of Crohn's & colitis

Avec: Karin Cerna , Dana Duricova , Miroslav Hindos , Jana Hindos Hrebackova , Martin Lukas , Nadezda Machkova , Veronika Hruba , Katarina Mitrova , Kristyna Kubickova , Kristyna Kastylova , Vladimir Teplan , Milan Lukas

A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn's disease: an analysis of two propensity score-matched cohorts.

Scandinavian journal of gastroenterology

Avec: M Lukas , M Kolar , J Reissigova , D Duricova , N Machkova , V Hruba , M Lukas , M Vasatko , J Jirsa , K Pudilova , K Malickova

Réseau de co-auteurs

Martin Lukas 5 collaborations

Milan Lukas 5 collaborations

Dana Duricova 4 collaborations

Veronika Hruba 4 collaborations

Katarina Mitrova 4 collaborations

Karin Cerna 3 collaborations

Kristyna Kubickova 3 collaborations

Kristyna Kastylova 3 collaborations

Marta Kostrejova 2 collaborations

K Malickova 2 collaborations

M Kolar 2 collaborations

M Vasatko 2 collaborations

N Machkova 2 collaborations

V Hruba 2 collaborations

D Duricova 2 collaborations

Vladimir Teplan 2 collaborations

M Lukas 2 collaborations

Martin Kolar 1 collaboration

Jakub Jirsa 1 collaboration

Stepan Peterka 1 collaboration

Gabriela Vojtechova 1 collaboration

M Bortlik 1 collaboration

Martin Vasatko 1 collaboration

Eva Dvorakova 1 collaboration

Ondrej Hradsky 1 collaboration

Marianna Durilova 1 collaboration

Jana Kozeluhova 1 collaboration

Pavel Kohout 1 collaboration

Kristyna Zarubova 1 collaboration

Jiri Bronsky 1 collaboration

Nora Hradska 1 collaboration

Eva Bronska 1 collaboration

Miroslava Adamcova 1 collaboration

Martin Bortlik 1 collaboration

Karin Malickova 1 collaboration

Miroslav Hindos 1 collaboration

Jana Hindos Hrebackova 1 collaboration

J Reissigova 1 collaboration

J Jirsa 1 collaboration

K Pudilova 1 collaboration